An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.
Saved in:
| Title: | An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss. |
|---|---|
| Authors: | Fukunaga T; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA., Zou W, Rohatgi N, Colca JR, Teitelbaum SL |
| Source: | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2015 Mar; Vol. 30 (3), pp. 481-8. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8610640 Publication Model: Print Cited Medium: Internet ISSN: 1523-4681 (Electronic) Linking ISSN: 08840431 NLM ISO Abbreviation: J Bone Miner Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
